| 1 |
Optimal management of drug-resistant tuberculosis |
|
| | Tiziana Masini, Jennifer Furin, Zarir Udwadia, Lorenzo Guglielmetti | | | Indian Journal of Medical Research. 2023; 157(2&3): 220 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions |
|
| | Paul Aliu, Séverine Sarp, Ramona Reichenbach, Sigrid Behr, Paige Fitzsimmons, Mansurahmad Shamlajee, Surya Prakash Kola, Samantha Nunes Radimerski, Emil Scosyrev | | | JAMA Health Forum. 2022; 3(4): e220475 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
COVID-19 e os desafios para a regulação de medicamentos em tempos de pandemia |
|
| | Vera Lúcia Edais Pepe, Hillegonda Maria Dutilh Novaes, Claudia Garcia Serpa Osorio-de-Castro | | | Ciência & Saúde Coletiva. 2021; 26(10): 4693 | | | [Pubmed] [Google Scholar] [DOI] | |
|
